Integrated Subcutaneous Monitoring and Delivery System

Publication ID: 24-11857218_0008_PTD

Published: November 07, 2025

Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Integrated Subcutaneous Monitoring and Delivery System,” Published Technical Disclosure No. 24-11857218_0008_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857218_0008_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,218.

Summary of the Inventive Concept

A novel system combining subcutaneous monitoring devices with advanced technologies like AI, IoT, blockchain, and nanomaterials to provide real-time personalized health recommendations and targeted therapeutic delivery.

Background and Problem Solved

The original subcutaneous delivery tool patent addressed the need for efficient implantation of medical devices. However, it lacked the capability to monitor physical parameters, provide real-time feedback, and integrate with emerging technologies. The new inventive concept solves this problem by creating a comprehensive system that integrates subcutaneous monitoring, data analysis, and targeted delivery.

Detailed Description of the Inventive Concept

The system consists of a subcutaneous monitoring device, a blockchain-based data storage unit, and a machine learning algorithm for analyzing the monitored data and generating personalized health recommendations. The system can be integrated with IoT-enabled wearable devices, cloud-based data analytics platforms, and nanomaterial-based coatings for enhanced biocompatibility. The micro-needle array is configured to deliver therapeutic agents to target sites, and the sensor detects the subcutaneous environment. The wearable device features a flexible, stretchable material-based sensor array, a power harvesting unit, and a wireless communication module.

Novelty and Inventive Step

The new claims introduce the integration of subcutaneous monitoring devices with AI, IoT, blockchain, and nanomaterials, which is not obvious from the original patent. The combination of these technologies enables real-time personalized health recommendations and targeted therapeutic delivery, providing a novel and non-obvious solution.

Alternative Embodiments and Variations

Alternative embodiments could include the use of different AI algorithms, varying IoT connectivity protocols, or alternative nanomaterials for enhanced biocompatibility. The system could also be adapted for use in various medical applications, such as diabetes management or cardiovascular monitoring.

Potential Commercial Applications and Market

The integrated subcutaneous monitoring and delivery system has significant commercial potential in the healthcare industry, particularly in the fields of personalized medicine, remote patient monitoring, and targeted therapeutic delivery. The system could be marketed to hospitals, clinics, and medical research institutions, and could also be used in consumer-facing applications, such as wearable devices for health and wellness monitoring.

CPC Classifications

Section	Class	Group
A	A61	A61B17/3468
A	A61	A61B5/29
A	A61	A61B17/32093
A	A61	A61B2017/320044
A	A61	A61B2017/320056
A	A61	A61N1/3756
A	A61	A61N1/37205

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Medical device technology, specifically subcutaneous monitoring and delivery systems, encompassing biomedical engineering, sensor design, and minimally invasive medical technologies

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with expertise in implantable sensors, microelectronics, materials science, and advanced medical monitoring technologies, typically holding a PhD or equivalent professional experience

Obviousness Rationale

A PHOSITA would recognize that integrating advanced digital technologies like AI, IoT, and blockchain with existing subcutaneous monitoring devices represents a predictable evolution of medical monitoring systems. The fundamental subcutaneous delivery mechanism remains consistent with the source patent, while the added technologies provide enhanced data processing and personalization capabilities. These technological integrations represent standard approaches to improving medical monitoring systems through known computational and communication techniques.

Obvious Combinations & Variations

Source Patent Element

Subcutaneous implantation device with channel for medical monitoring tool

PTD Variation

Adding IoT-enabled wireless communication and machine learning data analysis to the subcutaneous monitoring device

Obviousness Reasoning

Adding wireless communication and computational analysis to medical devices is a known technique for enhancing monitoring capabilities, representing a predictable technological improvement

Source Patent Element

Medical device designed for subcutaneous placement

PTD Variation

Incorporating nanomaterial-based biocompatible coatings and micro-needle array for targeted therapeutic delivery

Obviousness Reasoning

Material science improvements and targeted delivery mechanisms are standard design choices in medical device development, representing an obvious extension of existing subcutaneous device technologies

Source Patent Element

Implantation tool with visualization capabilities

PTD Variation

Integrating blockchain-based data storage and cloud analytics for personalized health monitoring

Obviousness Reasoning

Applying distributed data storage and advanced analytics to medical monitoring represents a standard approach to improving data management and patient insights

Source Patent Element

Subcutaneous monitoring device with sensor capabilities

PTD Variation

Adding flexible, stretchable sensor array with power harvesting unit

Obviousness Reasoning

Developing more advanced, adaptable sensor technologies is a predictable progression in medical device design, utilizing known materials science and sensor engineering techniques

Source Patent Element

Medical device for subcutaneous placement

PTD Variation

3D printing customized implantable devices based on machine learning analysis

Obviousness Reasoning

Personalized medical device manufacturing through computational analysis and additive manufacturing represents a standard approach to advanced medical technology development

35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857218 and the disclosed technological variations, a person having ordinary skill in the art would find the proposed subcutaneous monitoring and delivery system variations obvious, as they represent predictable technological extensions utilizing standard computational, communication, and materials science techniques known in the medical device engineering field.

Original Patent Information

Patent Number	US 11,857,218
Title	Subcutaneous delivery tool
Assignee(s)	Medtronic, Inc.